TD Cowen lowered the firm’s price target on DexCom (DXCM) to $84 from $100 and keeps a Buy rating on the shares. The firmsaid they possted a solid Q3 and they see many drivers kicking in despite management comments on 2026 growth.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXCM: